ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
Text_Chloroquine-phytochemical conjugation.docx (388.02 kB)
0/0

Newly Developed Semi-Synthetic Chloroquine and Hydroxychloroquine-Phytochemical Conjugates as Prospective COVID-19 Drug(s)

preprint
submitted on 26.04.2020 and posted on 27.04.2020 by Chita Ranjan Sahoo, Sudhir Kumar Paidesetty, Rabindra Padhy

Dear Editor,

Kindly find a research article entitled “Newly developed semi-synthetic chloroquine and hydroxychloroquine-phytochemical conjugates as prospective COVID-19 drug(s)”, submitted for consideration for publication. Kindly find the Herein, two series of chloroquine (CQ) and hydroxychloroquine (HCQ) derivatives were chemically conjugated with established small phenolic phytochemicals namely, thymol, vanillin, guaiacol, eugenol, 4-hydroxycoumarin and vanillin analogues by the principles of Williamson ether reaction. The HCQ-vanillin conjugation would be coveted as a potential candidate against human COVID-19.

Thanking you,

With regards,

Rabindra Nath Padhy, PhD, Post-Doc, Member NAMS.

Professor and Head, Central Research Laboratory, IMS & Sum Hospital,

Siksha ‘O’ AnusandhanDeemed to be University,

Bhubaneswar- 751003, Odisha, India.

E-mail: rnpadhy54@gmail.com


Funding

Siksha ‘O’ Anusandhan Deemed to University, Bhubaneswar, Odisha, India

History

Email Address of Submitting Author

rnpadhy54@gmail.com

Institution

IMS & SUM Hospital, Siksha ‘O’ Anusandhan Deemed to University, Bhubaneswar, Odisha, India

Country

India

ORCID For Submitting Author

0000-0002-2522-9843

Declaration of Conflict of Interest

Authors declare no conflict of interest.

Exports

Logo branding

Exports